HOT OFF THE PRESS OTCtipReporter.com BUY ALERT NOW
Tuesday's Alert (Inside) the "Green Rush is On" $35 Billion Market EXPLOSION
Dear Fellow Trader,
Immediately turn your attention to GreenLink International Inc. (WSHE)
Everyone is looking for the next household name in the CBD boom and "Greenlink International" could be on its way to becoming just that.
This Company is bringing the highest-grade CBD products to market and is in the process of getting these products out to the masses in a strategic way.
Consumers are growing tired of using products that have hundreds of chemicals in them and this has made CBD in skincare one of the most promising industries for growth.
This small-cap player strives to use 100% natural ingredients in their purest forms for all of their designer products.
Name: Greenlink International
Symbol: WSHE
Price: Approx. $.04
By The End of This Decade, Projections are That The CBD Market Will Expand 25-Fold, From Roughly $2 Billion Today to Over $50 Billion! Compared to The Marijuana Industry Forecast to Expand Only 2-Fold in The Same Time Period.
Image
Another bullish catalyst that could potentially send shares breaking out higher is Respected Technical Analysis site, Investing.com issued WSHE Bullish B·uy Rating, signaling a much bigger breakout could be imminent.
Image
Many cannabis investors are missing the future in this market by micro focusing on marijuana production. They’re overlooking the far bigger story that’s building in hemp production, the source plant for CBD extracts.
While recreational marijuana has been around virtually forever…the market for CBD extracts is still in its infancy…and it’s on a fast track to a $50 billion heavyweight outcome.
The numbers are stunning… and the investment potential more than obvious.
CBD market growth is projected to outpace THC market growth by more than 12-to-one.
This report I prepared for you below explains the huge discrepancy between the two sides of the cannabis market. And why, based on growth oppor·tunity alone, you should immediately shift your attention to the CBD side of the market.
More important, it explains how one little-known company (Ticker: WSHE), is positioned to evolve into one of the most important and largest producers of high purity CBD products in the world.
About Greenlink International
Greenlink, a Colorado corporation based in Washington State, is a public quoted OTC Markets issuer under the ticker symbol “WSHE”. The Company is a diversified holding company with operating segments in Investment, Equipment, Technology, Brands, Textiles and Real Estate that are leased or licensed to legally compliant CBD and cannabis entities.
Greenlink’s subsidiary and partner companies possess key competitive strengths and / or leading market positions. Greenlink is committed to becoming a global leader in the Hemp and le·gal Cannabis markets. Greenlink will continue to leverage decades of experience in the hemp and cannabis industry to expand existing operations and develop partnerships across a wide range of industries.
When it comes to CBD, it’s all about purity and it has to be flawless.
Not only are their technicals signaling potential breakout, Greenlink unveiled Suncliff Terpene Gems™, marking the first-ever category expansion into one of the most underserved sectors of the cannabis and hemp industry. Suncliff Terpene Gems™ open the door for consumers to explore a full range of experiences to manage their needs throughout the day without intoxication. The initial launch includes: Calm, Creative, Social and Energetic as the core experiences that are 100% free of controlled substances and can be sold globally.
Here’s a Snap Shot of News:
Greenlink (Ticker: WSHE) Just release Breaking News
Regarding a New Product Line Targeting Everyone!
Suncliff(TM) is Targeting a New Sector of the
Cannabis Industry: Everyone
TACOMA, WA / ACCESSWIRE / February 22, 2022 / Today Greenlink unveiled Suncliff Terpene Gems™, marking the first-ever category expansion into one of the most underserved sectors of the cannabis and hemp industry. Suncliff Terpene Gems™ open the door for consumers to explore a full range of experiences to manage their needs throughout the day without intoxication. The initial launch includes: Calm, Creative, Social and Energetic as the core experiences that are 100% free of controlled substances and can be sold globally.
When CBD meets the highest standards for purity, extracts can sell for upwards to $850 an ounce. To get those kind of prices requires stringent quality control through the entire farm to market process.
The Company I’ve Chosen As Our Top CBD Pick For 2022 is One of The Very Few Worldwide That Can Pull This Off. Everything is Managed to Produce The Purest Form of CBD Extracts Available Anywhere.
While many have entered the CBD space over the past few years and many have left, this little-known company "Greenlink International" (Ticker: WSHE) is here for the long haul. It has spent the past few years building one of the industries most complete infrastructures and is now poised to capitalize on what it has achieved. With quality hemp, extraction, testing, and formulation, along with packaging and retail this undervalued company is the perfect storm.
And right now they are embarking on its biggest expansion yet. The Company reports that it is now capable of producing 3x high purity CBD extracts per year!
How valuable is that? It can be better than owning a gold mine!
Simple math shows that CBD can generate larger, virtually unending revenue streams with substantially lower capital expenditures (CAPEX) and production costs than mining for gold.
A gold mine with a million ounces in reserves may generate $1.5 to $3.0 million net annual revenue over the limited life of the mine.
CBD production, by comparison, has no life limitation. What’s more, and most importantly, 1 million ounces of high-purity CBD extract could generate $20 to $30 million net revenue annually! (As example).
That’s up to ten-times the potential from mining gold!
And there’s no end to it! Greenlink International" (WSHE) CBD production target of CBD per year can be ongoing for decades…it’s only a starting point!
Their current production target is limited only by the CBD content of the raw hemp it processes. As more higher CBD content strains of hemp are developed, annual production CBD extracts could double, triple or more annually.
Again, look at the meteoric growth curve projected for CBD extracts. And it’s not just for anything that can be labeled CBD. As a pharmaceutical product, CBD must be expertly extracted, labeled accurately and produced at the highest grade of purity.
The medicinal potential in CBD compounds extends from over-the-counter medications to disease-targeting prescription pharmaceuticals. Regardless of intended use, the quality must be absolute and the supply scalable to the need. Lives will depend on both.
Greenlink International (WSHE) Has Positioned Itself to
Market 8 Different CBD Product Lines
Keep in mind that there are dozens of CBD like molecules that can be extracted from the hemp plant…and many of these unique molecules carry very different pharmaceutical potential (over 85 cannabinoids have been identified to date).
This PubMed report issued through the National Library of Medicine, National Institute of Health points to the vital importance of pure, highly targeted CBD extraction. That purity, so essential to pharmaceutical use, may only be made possible through the tightly controlled, vertically integrated processes.
“Cannabidiol, or CBD, is one of at least 85 active cannabinoids identified within the Cannabis plant. It is a major phytocannabinoid, accounting for up to 40% of the [hemp] plant’s extract, that binds to a wide variety of physiological targets of the endocannabinoid system within the body.”
“CBD has shown promise as an analgesic, anticonvulsant, muscle relaxant, anxiolytic, antipsychotic and has shown neuroprotective, anti-inflammatory, and antioxidant activity, among other currently investigated uses.”
Greenlink International Management Team Poised For Success
Jake George: President & CEO with a decade of experience in the cannabis industry, Jake George is widely recognized as one of the first professionals to enter the cannabis space.
Raonall Smith: Mr. Smith is a retired NFL linebacker with a degree in Marketing and a key member of our CBD impact team. His leadership will shape our CBD program for decades to come.
Brendan Mckenna: Mr. McKenna is a nationally recognized health expert with a focus on Tribal Sovereignty, Indian Law and Tribal Governance.
Doug Macdonald: As a former Law Enforcement Officer with decades of experience in the financial industry, Mr. MacDonald is an authority on Canadian law enforcement and compliance.
Judy Campbell: 30 Years specializing in Real Estate and development gives Mrs. Campbell a unique business prospective. She is our resident advisor on all things relating to real estate and core business strategy.
Richard Schmidtke: Corporate Treasurer, Mr. Schmidtke will undertake a range of strategic financial risk management activities that enable GreenLink International to maintain, improve and maximize our financial position.
Now is the time for you to get in front of this little-known stock. Greenlink International (WSHE) priced approx. $.04/share.
For an investor, particularly now at the entry-level stage, production scaling can lead to enormous potential in the years ahead. Stay tuned in to receive more information about this innovative young company that is poised to take the lead.
I am urging all of our members to add WSHE to the top of your watch list right now, and have it pulled up on your trading screen Tuesday morning at the opening bell!
Regards,
Image
Jamie Rothstein
Editor In Chief, OTCTipReporter
